Weight Loss Injections in Bournemouth: What You Need to Know Before Starting

Which injections are actually licensed for weight loss in the UK?

Two, and only two. Mounjaro, made by Eli Lilly, contains tirzepatide and works on both the GIP and GLP-1 receptors, making it the only dual-pathway weight-loss injection available here. Wegovy, made by Novo Nordisk, contains semaglutide and acts on the GLP-1 receptor alone. Both slow gastric emptying and reduce appetite, but through slightly different mechanisms.

A name worth clarifying: Ozempic is also semaglutide, but it is licensed for type 2 diabetes, not weight management. It's not a weight loss injection in any formal sense, and prescribing it for that purpose off-label is not the same as prescribing Wegovy. The NHS medicines page for tirzepatide sets out the full licensed indication if you want to read the detail.

If you're trying to work out which of the two suits you better, a comparison of the two injections for weight loss covers the clinical differences clearly, including the head-to-head SURMOUNT-5 trial data.

Saxenda (liraglutide) is a third injection that used to be prescribed for weight management but is not something we dispense, and availability has become very limited across UK services generally.

Does BMI alone decide whether you can get a prescription?

It's the starting point, not the whole picture. The licensed eligibility for both Mounjaro and Wegovy is a BMI of 30 or above, or 27 or above if you have at least one weight-related health condition, things like high blood pressure, prediabetes, high cholesterol, or obstructive sleep apnoea. For some ethnic backgrounds, UK clinical guidance applies thresholds that are 2.5 kg/m² lower than the standard figures.

BMI, though, is a filter rather than a verdict. A prescriber also considers your medical history, current medications, and any conditions that would make either injection unsuitable, a history of pancreatitis, for example, or medullary thyroid cancer. Under-18s are not eligible, and neither injection is recommended during pregnancy, while breastfeeding, or if you're trying to conceive.

There's a practical overview of the full eligibility criteria for UK weight loss injections if you want to check the specifics before starting a consultation. The NHS BMI calculator is also a straightforward tool if you want to confirm your number first.

How does getting a prescription actually work without a local clinic?

For most people in Bournemouth, there are three routes: a GP referral into an NHS specialist weight management service (where Wegovy may be available, but waits can be long and criteria are strict under NICE TA875), a private in-person clinic, or a regulated online pharmacy. All three require a prescription; the difference is speed, access criteria, and cost.

Through a GPhC-registered online pharmacy like ours, the process is: a free consultation completed online, reviewed the same day by a real prescriber rather than automated software, with photo-ID verification and live weight confirmation built in. Once approved, the pen is dispatched from our pharmacy and arrives the next working day via DPD, tracked to your door, in plain unbranded packaging. The KwikPen itself is compact and pre-filled; most people find the injection much less intimidating than they expected.

You can read more about what weight loss injections cost through a private service, including what a quoted price typically does and doesn't include. For context on how our pharmacy operates, the about-us page explains our clinical structure and GPhC registration (premises number 9012878, verifiable at pharmacyregulation.org).

What side effects should people starting in Bournemouth expect?

The side-effect profile of both injections is dominated by gastrointestinal symptoms: nausea, loose stools, constipation, burping, reflux, and occasionally vomiting. These tend to peak in the first few days after a new dose and ease off as your body adjusts. Fatigue and mild headaches are reported by some people in the early weeks too.

The MHRA issued a Drug Safety Update in January 2026 drawing attention to acute pancreatitis as a known, though infrequent, serious risk with GLP-1 medicines. Severe abdominal pain that radiates to the back, especially if it doesn't ease, is a reason to seek urgent medical attention rather than waiting. The MHRA Yellow Card scheme lets patients report any suspected side effects directly, and doing so helps build the UK safety picture for these medicines.

Injection-site reactions (mild redness or tenderness where the pen was used) are common and usually minor. Rotating your injection site between your abdomen, thigh, and upper arm helps reduce them. For the full side-effect list and storage instructions, your Patient Information Leaflet is the definitive source; our prescribers are also available seven days a week if something concerns you mid-treatment.

For a broader look at what clinical evidence and patient experience show together, and for anyone based in the South West who wants local context, our guide to weight loss injections in Plymouth is worth reading before you decide, as is the truth about weight loss injections more generally.